Image de couverture de livre

Correction to “Targeting lncRNA DDIT4‐AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy”

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	Advanced Science
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

RNA G‐Quadruplex RIBOTAC‐Mediated Targeted Degradation of lncRNA TERRA
par: Elias Khaskia, et autres
Publié: (2025)

NUSAP1 Recruits DAXX to Suppress HIF‐Driven Triple‐Negative Breast Cancer Progression
par: Yating Du, et autres
Publié: (2025)

HDAC2‐Mediated METTL3 Delactylation Promotes DNA Damage Repair and Chemotherapy Resistance in Triple‐Negative Breast Cancer
par: Xiaoniu He, et autres
Publié: (2025)

GPX4 Inhibitor Resistance and Metastatic Features in Triple‐Negative Breast Cancer
par: Marie Sabatier, et autres
Publié: (2026)

Serine/Threonine Kinase 33 as a Novel Target of Bufalin in Treatment of Triple‐Negative Breast Cancer
par: Shilong Jiang, et autres
Publié: (2025)

ITGB1 Regulates Triple‐Negative Breast Cancer Development by Modulating the Tumor Microenvironment
par: Nuozi Song, et autres
Publié: (2026)

Type II Alveolar Epithelial Cells Promote Sepsis‐Induced Immunosuppression in Alveolar Macrophages via Exosomal lncRNA Rmrp Release
par: Chengxi Liu, et autres
Publié: (2025)

Tetrastigma Hemsleyanum Polysaccharide Suppresses Triple‐Negative Breast Cancer by Disrupting the Hippo‐YAP/TEAD4‐PDIA4 Axis and Endoplasmic Reticulum Stress Adaptation
par: Yini Shang, et autres
Publié: (2026)

LncRNA FAISL Inhibits Calpain 2‐Mediated Proteolysis of FAK to Promote Progression and Metastasis of Triple Negative Breast Cancer
par: Yunmei Zhang, et autres
Publié: (2024)

Targeting IL27RA Enhances Immunotherapy in Triple‐Negative Breast Cancer by Modulating Tumor Cells and the Tumor Microenvironment
par: Jiachi Xu, et autres
Publié: (2026)

Targeting IGF1R Overcomes Armored and Cold Tumor Microenvironment and Boosts Immune Checkpoint Blockade in Triple‐Negative Breast Cancer
par: Mengyun Wan, et autres
Publié: (2025)

WDR5‐H3K4me3 Epigenetic Axis Promotes TRMT6‐Dependent tRNA M 1 A Modification to Facilitate Triple‐Negative Breast Cancer Progression by Suppressing Ferroptosis
par: Yuqing Lei, et autres
Publié: (2025)

Single‐Cell Computational Frameworks for Quantifying BET Bromodomain Inhibitor Resistance and Screening Re‐Sensitizer Drugs in Triple‐Negative Breast Cancer
par: Haizhou Liu, et autres
Publié: (2026)

Pharmacologic Modulation of ARID3A with Rimegepant Reactivates Type I Interferon Signaling and Sensitizes Triple‐Negative Breast Cancer to PD‐1 Blockade
par: Teng Zhou, et autres
Publié: (2026)

Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid Metabolism
par: Elysse C. Filipe, et autres
Publié: (2024)

mRNA‐Lipid Nanoparticle‐Mediated Restoration of PTPN14 Exhibits Antitumor Effects by Overcoming Anoikis Resistance in Triple‐Negative Breast Cancer
par: Wei Li, et autres
Publié: (2024)

Logic‐Gated HSV‐TK/GCV Suicide Gene Circuit for Triple‐Negative Breast Cancer
par: Shasha Tang, et autres
Publié: (2026)

Pyroptosis‐Inducing Platinum(IV) Prodrugs via GSDME Pathway for Chemoimmunotherapy and Metastasis Inhibition in Triple‐Negative Breast Cancer
par: Xinda Yang, et autres
Publié: (2025)

Combined Photothermal and mTOR‐Targeted Therapy Overcomes Immune Evasion and Enhances Checkpoint Blockade Efficacy in Metastatic Triple‐Negative Breast Cancer
par: Yujie Zhao, et autres
Publié: (2025)

Correction to “RNF126‐Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple‐Negative Breast Cancer to Radiotherapy”
Publié: (2025)

Novel ATR/PARP1 Dual Inhibitors Demonstrate Synergistic Antitumor Efficacy in Triple‐Negative Breast Cancer Models
par: Yuan Gao, et autres
Publié: (2025)

Improved Efficacy of Triple‐Negative Breast Cancer Immunotherapy via Hydrogel‐Based Co‐Delivery of CAR‐T Cells and Mitophagy Agonist
par: Guodong Li, et autres
Publié: (2025)

Antibody and siRNA Nanocarriers to Suppress Wnt Signaling, Tumor Growth, and Lung Metastasis in Triple‐Negative Breast Cancer
par: Megan N. Dang, et autres
Publié: (2024)

Genetically Engineered Light‐Responsive In Situ Hydrogels for Immunomodulation and Multimodal Therapy in Metastatic Triple‐Negative Breast Cancer
par: Xinchen Shen, et autres
Publié: (2025)

Senescence‐Inducing Therapy Sequential NIR‐II Mild Photothermal/Senolytic Therapy of Triple Negative Breast Cancer
par: Liya Yu, et autres
Publié: (2025)

A Multifunctional Bimetallic Nanoplatform for Synergic Local Hyperthermia and Chemotherapy Targeting HER2‐Positive Breast Cancer
par: Li Zhao, et autres
Publié: (2024)

Correction to “Terpenoids From Quinoa Reverse Chemoresistance in Breast Cancer by Suppressing the Stemness‐Related lncRNA 667012”
Publié: (2025)

Concurrent Amplification of Ferroptosis and Immune System Activation Via Nanomedicine‐Mediated Radiosensitization for Triple‐Negative Breast Cancer Therapy
par: Reyida Aishajiang, et autres
Publié: (2024)

PRMT5/Sohlh2/Sirt1 Signaling Pathway in Vascular Endothelial Cells Modulates Lung Metastasis of Triple‐Negative Breast Cancer
par: Ruihong Zhang, et autres
Publié: (2026)

Triple‐Negative Breast Cancer Cells Resist Natural Killer Cell‐Mediated Killing Through Interleukin‐11 Trans‐Signaling
par: Hongmei Yang, et autres
Publié: (2025)

A Self‐Assembling LYTAC Mediates CTGF Degradation and Remodels Inflammatory Tumor Microenvironment for Triple‐Negative Breast Cancer Therapy
par: Jia‐Yi Lin, et autres
Publié: (2025)

Polyamine Anabolism Promotes Chemotherapy‐Induced Breast Cancer Stem Cell Enrichment
par: Guangyu Ji, et autres
Publié: (2024)

Universal Antibody‐Engineered Lipid Nanoparticles Potentiate Chemo‐Immunotherapy Against Triple‐Negative Breast Cancer by Reprogramming Tumor Cell Metabolism
par: Yeneng Dai, et autres
Publié: (2026)

19 F MRI/CEUS Dual Imaging‐Guided Sonodynamic Therapy Enhances Immune Checkpoint Blockade in Triple‐Negative Breast Cancer
par: Qiu Chen, et autres
Publié: (2024)

Autonomous Soft Nanorobots for Active Targeting and Therapy of Triple‐Negative Breast Cancer
par: Wei Lu, et autres
Publié: (2025)

ML‐Based Screening of miRNA Inhibitors and Intervention of lncRNA/miRNA/mRNA Axis in Oncogenic KRAS‐Associated Colorectal Cancer
par: Prasanna Srinivasan Ramalingam, et autres
Publié: (2024)

TRIM38 Suppresses Breast Cancer Progression via Modulating SQSTM1 Ubiquitination and Autophagic Flux
par: Shan Jiang, et autres
Publié: (2025)

Lactate Dehydrogenase C4 Accelerates Triple‐Negative Breast Cancer Progression by Promoting Acetyl‐CoA Acyltransferase 2 Lactylation to Increase Free Fatty Acid Accumulation
par: Zhaolei Cui, et autres
Publié: (2025)

Biomimetic Organic Nanozyme as Tumor Vaccines for Targeted Suppression of Ammonia‐Induced T Lymphocyte Death to Augment Breast Cancer Immunotherapy
par: Meng Suo, et autres
Publié: (2025)

MYC/TET3‐Regulated TMEM65 Activates OXPHOS‐SERPINB3 Pathway to Promote Progression and Cisplatin Resistance in Triple‐Negative Breast Cancer
par: Yin‐Ling Zhang, et autres
Publié: (2025)